Amputation Risks from Invokana Questioned in Study By Manufacturer
A new study by the makers of Invokana claim that the diabetes drug’s side effects do not cause any higher rates of lower limb amputation than similar diabetes drugs.…
«
»
A new study by the makers of Invokana claim that the diabetes drug’s side effects do not cause any higher rates of lower limb amputation than similar diabetes drugs.…
A growing number of lawsuits over claims that Byetta, Victoza and similar diabetes drugs can cause pancreatic cancer are being filed in the wake of a recent decision to reinstate the litigation.…
A new study warns that rates of pregnancy complications are higher with DiaBeta, Micronase and similar drugs than with insulin when used to treat pregnant women with gestational diabetes.…
Rates of hospitalization due to diabetic ketoacidosis are on the rise in recent years, and Invokana and similar drugs may be contributing to that increase, according to the CDC.…
A new schedule for Byetta, Januvia and Victoza pancreatic cancer lawsuits sets the first bellwether trial for January 2020.…
A product liability lawsuit indicates that the side effects of Farxiga and Xigduo XR led to an Indiana man suffering diabetic ketoacidosis and acute kidney injury.…
A panel of federal judges hears oral arguments today on whether federal lawsuits over the side effects of Onglyza, a diabetes drug by AstraZeneca, should be consolidated before one judge for pretrial proceedings.…
A new Onglyza lawsuit filed by an Illinois man indicates that the diabetes drug caused him to suffer congestive heart failure.…
The U.S. Judicial Panel on Multidistrict Litigation has agreed to hear oral arguments over the creation of an MDL centralizing Onglyza heart failure lawsuits at a hearing session in late January. …
More than 700 Victoza, Byetta, Januvia and Janumet pancreatic cancer lawsuits have been reinstated by a federal appeals court, overturning a summary judgment that led to their dismissal in 2015.…